The following new grants were awarded to JCCC members, announced in February 2012:
Sponsor Name: Genentech, Inc.
Award Title: Phase III, Multicenter, Open-label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-positive Diffuse Large B-cell Lymphoma (DLBCL)
Principal Investigator: Schiller, Gary
Sponsor Name: University Health Network
Award Title: Phase 1 Study Evaluating the Tolerance and Biologic Activity of Intravenous Infusions of Tigecycline in Patients With Relapsed or Refractory AML
Principal Investigator: Wainberg, Zev
Sponsor Name: Medpace, Inc.
Award Title: Randomized Phase 2 Study of Ruxolitinib Efficacy and Safety in Combination With CApecitabine for Subjects With Recurrent or Treatment Refractory Metastatic Pancreatic Cancer (The RECAP Trial)
Principal Investigator: Weiss, Shimon
Sponsor Name: United States Israel Binational Science Foundation (Bsf)
Award Title: Detection of Single PRI- MIRNA Processing Events in Live Cell